Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-33293988

ABSTRACT

Teucrium leucocladum is among the most used traditional medicinal plants in Palestine, which is used for the treatment of hyperglycemia and colon spasms from ancient times. Therefore, the current investigation aimed for the first time to determine the hypoglycemic, hypolipidemic, and oxidative stress inhibitory effects of the aerial parts (stem and leaves) of T. leucocladum hydrophilic (water) extract in streptozotocin- (STZ-) induced diabetic rats (65 mg/kg), given intraperitoneally at a dose of 100 mg/kg for 21 days. The rats were divided into four groups as control (C), control + T. leucocladum extract (C + TL), diabetes (D), and diabetes + T. leucocladum extract (D + TL). The antioxidant activity was analyzed using in vitro 2,2-diphenyl-1-picrylhydrazyl and in vivo methods by measuring the plasma and tissue malondialdehyde (MDA) levels using a colorimetric assay. On the other hand, glutathione peroxidase (GSH-Px), erythrocyte superoxide dismutase (SOD) enzyme levels, serum paraoxonase (PON), and arylesterase (ARE) enzyme activities were assessed by utilizing standard biochemical kits. Besides, the blood glucose and serum insulin levels were assessed by a glucometer and Rat ELISA Kit, respectively. However, the autoanalyzer was used to evaluate the lipid profile. The diabetic rat group that administered T. leucocladum extract showed the best reduction in the tissue and plasma MDA levels and an increase of insulin-releasing potentials. Besides, the serum PON and ARE activities and erythrocyte superoxide dismutase and whole blood glutathione peroxidase enzyme levels were significantly increased in all animals treated with T. leucocladum extract. The current investigation demonstrated that T. leucocladum manifests antihyperglycemic and antihyperlipidemic effects and also increased the antioxidative defense system and reduced the lipid peroxidation process in experimental diabetic rats.

2.
Food Chem Toxicol ; 81: 54-61, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25846499

ABSTRACT

Oxidative stress occurs following the impairment of pro-oxidant/antioxidant balance in chronic wounds and leads to harmful delays in healing progress. A fine balance between oxidative stress and endogenous antioxidant defense system may be beneficial for wound healing under redox control. This study tested the hypothesis that oxidative stress in wound area can be controlled with systemic antioxidant therapy and therefore wound healing can be accelerated. We used chlorogenic acid (CGA), a dietary antioxidant, in experimental diabetic wounds that are characterized by delayed healing. Additionally, we aimed to understand possible side effects of CGA on pivotal organs and bone marrow during therapy. Wounds were created on backs of streptozotocin-induced diabetic rats. CGA (50 mg/kg/day) was injected intraperitoneally. Animals were sacrificed on different days. Biochemical and histopathological examinations were performed. Side effects of chronic antioxidant treatment were tested. CGA accelerated wound healing, enhanced hydroxyproline content, decreased malondialdehyde/nitric oxide levels, elevated reduced-glutathione, and did not affect superoxide dismutase/catalase levels in wound bed. While CGA induced side effects such as cyto/genotoxicity, 15 days of treatment attenuated blood glucose levels. CGA decreased lipid peroxidation levels of main organs. This study provides a better understanding for antioxidant intake on diabetic wound repair and possible pro-oxidative effects.


Subject(s)
Chlorogenic Acid/pharmacology , DNA Damage/drug effects , Diabetes Mellitus, Experimental/pathology , Wound Healing/drug effects , Animals , Antioxidants/pharmacology , Blood Glucose/metabolism , Catalase/metabolism , Glutathione/metabolism , Hydroxyproline/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Streptozocin , Superoxide Dismutase/metabolism
3.
ScientificWorldJournal ; 2014: 351598, 2014.
Article in English | MEDLINE | ID: mdl-25431786

ABSTRACT

The purpose of this study was to investigate the effects of vitamin B6 (Vit B6) on oxidant and antioxidant status in streptozotocin-induced diabetic rats. Thirty-two Wistar rats were divided into four groups: control (C), control + Vit B6 group (C + Vit B6), diabetes (D), and diabetes + Vit B6 group (D + Vit B6). Vit B6 (4 mg/kg body weight) was administered in drinking water for 4 weeks after the induction of diabetes. Vitamin B6 reduced serum total cholesterol level in the C + Vit B6 (P < 0.01) and D + Vit B6 (P < 0.05) groups. Plasma and tissue malondialdehyde levels were reduced in the C + Vit B6 and D + Vit B6 groups. Whole blood glutathione peroxidase (GSH-Px) and erythrocyte superoxide dismutase (SOD) activities were higher in the D group (P < 0.05). GSH-Px and SOD activities were increased in C + Vit B6 group while these parameters decreased in the D + Vit B6 group. Paraoxonase and arylesterase activities were decreased in the D group while they were increased in C + Vit B6 and D + Vit B6 groups. The results of present study suggest that vitamin B6 supplementation might be a promising adjunctive agent for improving oxidative stress and metabolic disturbances and for preventing diabetic complications including atherogenesis.


Subject(s)
Antioxidants/pharmacology , Aryldialkylphosphatase/blood , Carboxylic Ester Hydrolases/blood , Diabetes Mellitus, Experimental/drug therapy , Vitamin B 6/pharmacology , Administration, Oral , Animals , Atherosclerosis/prevention & control , Cholesterol/blood , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/enzymology , Drug Administration Schedule , Enzyme Activation/drug effects , Erythrocytes/chemistry , Erythrocytes/drug effects , Erythrocytes/enzymology , Glutathione Peroxidase/blood , Male , Malondialdehyde/metabolism , Oxidative Stress/drug effects , Rats , Rats, Wistar , Streptozocin , Superoxide Dismutase/metabolism
4.
Naunyn Schmiedebergs Arch Pharmacol ; 387(11): 1101-16, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25129377

ABSTRACT

Chlorogenic acid (CGA) is a well-known natural antioxidant in human diet. To understand the effects of CGA on wound healing by enhancing antioxidant defense in the body, the present study sought to investigate the potential role of systemic CGA therapy on wound healing and oxidative stress markers of the skin. We also aimed to understand whether chronic CGA treatment has side effects on pivotal organs or rat bone marrow during therapy. Full-thickness experimental wounds were created on the backs of rats. CGA (25, 50, 100, 200 mg/kg) or vehicle was administered intraperitoneally for 15 days. All rats were sacrificed on the 16th day. Biochemical, histopathological, and immunohistochemical examinations were performed. Possible side effects were also investigated. The results suggested that CGA accelerated wound healing in a dose-dependent manner. CGA enhanced hydroxyproline content, decreased malondialdehyde and nitric oxide levels. and elevated reduced glutathione, superoxide dismutase, and catalase levels in wound tissues. Epithelialization, angiogenesis, fibroblast proliferation, and collagen formation increased by CGA while polymorph nuclear leukocytes infiltration decreased. CGA modulated matrix metalloproteinase-9 and tissue inhibitor-2 expression in biopsies. Otherwise, high dose of CGA increased lipid peroxidation of liver and kidney without affecting the heart and muscle samples. Chronic CGA increased micronuclei formation and induced cytotoxicity in the bone marrow. In conclusion, systemic CGA has beneficial effects in improving wound repair. Antioxidant, free radical scavenger, angiogenesis, and anti-inflammatory effects of CGA may ameliorate wound healing. High dose of CGA may induce side effects. In light of these observations, CGA supplementation or dietary CGA may have benefit on wound healing.


Subject(s)
Antioxidants/pharmacology , Chlorogenic Acid/pharmacology , Oxidative Stress/drug effects , Wound Healing/drug effects , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/toxicity , Antioxidants/administration & dosage , Antioxidants/toxicity , Chlorogenic Acid/administration & dosage , Chlorogenic Acid/toxicity , Dose-Response Relationship, Drug , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/pharmacology , Free Radical Scavengers/toxicity , Lipid Peroxidation/drug effects , Male , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Skin/drug effects , Skin/metabolism
5.
Acta Biol Hung ; 65(1): 13-26, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24561891

ABSTRACT

The presence of chromosomal damage in bone marrow cells affected by several diseases such as thyroid, cancer etc., was detected by the micronucleus (MN) assay. The present study was designed to evaluate: i) volatile components of Ulva rigida, ii) effects of hypothyroidism on bone marrow MN frequency, iii) effects of oral administration of Ulva rigida ethanolic extract (URE) on MN frequency produced by hypothyroidism, and iv) thyroid hormone levels in normal and 6-n-Propylthiouracil (PTU)-induced hypothyroid rats. The volatile components of Ulva rigida was studied using a direct thermal desorption (DTD) technique with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry (GCxGC-TOF/MS). URE administration was of no significant impact on thyroid hormone levels in control group, while PTU administration decreased thyroid hormone levels compared to control group (p < 0.001). Moreover, URE supplementation resulted in a significant decrease in MN frequency in each thyroid group (p < 0.0001). This is the first in vivo study that shows the strong antigenotoxic and protective effect of URE against the genotoxicity produced by hypothyroidism.


Subject(s)
DNA Damage/drug effects , Hypothyroidism/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Ulva/chemistry , Animals , Cell Nucleus/drug effects , Drug Evaluation, Preclinical , Male , Micronucleus Tests , Plant Extracts/pharmacology , Rats , Rats, Wistar
6.
Cell Biochem Funct ; 29(2): 108-13, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21370246

ABSTRACT

This study was designed to investigate the effects of Ulva rigida, one of the green algae, on the lipid profile and oxidative-antioxidative systems in streptozotocin-induced diabetic rats. Forty Wistar rats randomly divided into four groups: control (C), control + U. rigida extract (C + URE), diabetes (D) and diabetes + U. rigida extract (D + URE). U. rigida (2%) was administered in drinking water for 5 weeks after the induction of diabetes. U. rigida reduced the blood glucose, serum total cholesterol, triglyceride levels and plasma and tissue malondialdehyde (MDA) levels in the D + URE group. Insulin levels were significantly higher in the D + URE than those of the D group. Serum total cholesterol and tissue MDA levels were reduced in the C + URE group. Whole blood glutathione peroxidase and erythrocyte superoxide dismutase activities were higher in the D and C + URE groups compared with the C group. Paraoxonase and arylesterase activities were lower in the D group while U. rigida increased paraoxonase activities in C + URE and D + URE groups. This is the first study which showed U. rigida has antidiabetic and antihyperlipidemic effects and improves oxidative stress in diabetic rats. We conclude that U. rigida might have a potential use as a protective and/or therapeutic agent in diabetes mellitus.


Subject(s)
Carbohydrate Metabolism/drug effects , Diabetes Mellitus, Experimental/drug therapy , Hyperlipidemias/drug therapy , Oxidative Stress/drug effects , Plant Preparations/administration & dosage , Ulva/chemistry , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental/metabolism , Disease Models, Animal , Humans , Hyperlipidemias/metabolism , Male , Malondialdehyde/blood , Random Allocation , Rats , Rats, Wistar
7.
Food Chem Toxicol ; 47(8): 1837-40, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19422873

ABSTRACT

An increased reactive oxygen species (ROS) and insufficient antioxidant activity is known in diabetes mellitus (DM). Antioxidant compounds in the human foods or supplementary diets can be used to counteract several diseases. The analysis of micronuclei (MN) is a cytogenetic technique used to show chromosomal damage caused by clastogenic affects. The present study was designed to evaluate: (i) the effects of diabetes mellitus on bone marrow MN frequency, (ii) the effect of oral administration of Ulva rigida ethanolic extract (URE) on MN frequency produced by DM, and (iii) some hematological values in normal and streptozotocin-induced diabetic rats. Daily fluid and food consumptions, weekly body weights, blood glucose concentrations and serum insulin levels were also examined in the study groups during the two different administration periods. The blood glucose concentration and MN frequency have been significantly increased in diabetic rats compared with the normal rats (p<0.0001). Especially, URE-30d group treatment in diabetic rats was significantly decreased blood glucose concentrations and MN frequency. This is the first report on the anti-hyperglycemic, anti-oxidative and genotoxic/antigenotoxic capacity of U. rigida in vivo. Our results suggest that URE shows strong anti-hyperglycemic and antigenotoxic effect on the genotoxicity produced by DM in rats.


Subject(s)
Antimutagenic Agents/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Ulva/chemistry , Animals , Blood Glucose/metabolism , DNA Damage , Diabetes Mellitus, Experimental/blood , Ethanol , Insulin/blood , Male , Micronucleus Tests , Plant Extracts/pharmacology , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Solvents , Turkey
8.
Clin Exp Pharmacol Physiol ; 34(9): 833-7, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17645625

ABSTRACT

1. Hypothyroidism is accompanied by hyperlipidaemia and oxidative stress and is associated with several complications, such as atherosclerosis. Paraoxonase activity has been reported to decrease in several situations associated with atherosclerosis and oxidative stress. In the present study, the effects of different doses of taurine on serum paraoxonase and arylesterase activities, as well as on the serum lipid profile, were investigated in hypothyroid rats. 2. Forty male Sprague-Dawley rats were randomly divided into five groups as follows: Group 1, rats received normal rat chow and tap water; Group 2, rats received standard rat chow + 0.05% propylthiouracil (PTU) in the drinking water; and Groups 3-5, taurine-supplemented PTU groups (standard rat chow + 0.5, 2 or 3% taurine in the drinking water, respectively, in addition to PTU). Paraoxon or phenylacetate were used as substrates to measure paraoxonase and arylesterase activity, respectively. Plasma and tissue malondialdehyde (MDA) levels, indicators of lipid peroxidation, were determined using the thiobarbituric-acid reactive substances method. Serum triglyceride, total cholesterol and high-density lipoprotein-cholesterol (following precipitation with dextran sulphate-magnesium chloride) were determined using enzymatic methods. 3. Serum paraoxonase and arylesterase activities were increased and plasma and tissue MDA levels and serum triglyceride levels were reduced in a dose-dependent manner in taurine-treated hypothyroid rats. Taurine concentrations were positively correlated with enzyme activities and negatively correlated with MDA and triglyceride levels. 4. Further studies are needed to investigate the role of taurine supplementation in hypothyroidism in human subjects.


Subject(s)
Antioxidants/pharmacology , Aryldialkylphosphatase/blood , Carboxylic Ester Hydrolases/blood , Dietary Supplements , Hypothyroidism/drug therapy , Taurine/pharmacology , Animals , Antioxidants/therapeutic use , Cholesterol/blood , Cholesterol, HDL/blood , Disease Models, Animal , Dose-Response Relationship, Drug , Hypothyroidism/chemically induced , Hypothyroidism/enzymology , Hypothyroidism/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Paraoxon/metabolism , Phenylacetates/metabolism , Propylthiouracil , Rats , Rats, Sprague-Dawley , Taurine/therapeutic use , Triglycerides/blood , Up-Regulation
9.
Arch Med Res ; 38(3): 276-83, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17350476

ABSTRACT

BACKGROUND: Vanadyl sulfate (VS) and taurine are two promising agents in the treatment of diabetes related to their antihyperglycemic, antihyperlipidemic, and hyperinsulinemic effects. Data about the effects of VS on the oxidant-antioxidant system is limited and controversial. However, taurine is a well-documented antioxidant agent and our aim was to investigate the effects of VS, taurine and VS and taurine combination on the oxidative-antioxidative systems in streptozotocin-nicotinamide (STZ-NA) diabetic rats. METHODS: Nicotinamide (230 mg/kg, i.p.) and streptozotocin (65 mg/kg, i.p.) were administered. VS (0.75 mg/mL) and taurine (1%) were added to drinking water for 5 weeks. Rats were divided as control (C), diabetes (D), diabetes+VS (D+VS), diabetes+taurine (D+T), diabetes+VS and taurine (D+VST). Plasma and tissue malondialdehyde (MDA) levels were measured by high-performance liquid chromatography and spectrophotometry, respectively. Paraoxonase and arylesterase activities were measured by spectrophotometric methods and superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were determined using commercial kits. RESULTS: VS, taurine and VS and taurine combination treatments reduced the enhanced blood glucose, serum total cholesterol and triglyceride, tissue MDA and plasma MDA (except in the D+VS group) levels and increased the reduced serum insulin level, serum paraoxonase and arylesterase activities, GSH-Px activity and SOD activity (except in the D+VS group). CONCLUSIONS: The findings of the present study suggest that VS and taurine exert beneficial effects on the blood glucose and lipid levels in STZ-NA diabetic rats. However, VS might exert prooxidative or antioxidative effects in various components of the body and taurine and VS combination might be an alternative for sole VS administration.


Subject(s)
Antioxidants/metabolism , Diabetes Mellitus, Experimental , Hypoglycemic Agents/metabolism , Oxidants/metabolism , Taurine/metabolism , Vanadium Compounds/metabolism , Animals , Antioxidants/administration & dosage , Blood Glucose/metabolism , Hypoglycemic Agents/administration & dosage , Liver/metabolism , Male , Malondialdehyde , Muscle, Skeletal/metabolism , Myocardium/metabolism , Oxidation-Reduction , Oxidative Stress , Rats , Rats, Wistar , Taurine/administration & dosage , Vanadium Compounds/administration & dosage
10.
Cell Biochem Funct ; 24(2): 153-8, 2006.
Article in English | MEDLINE | ID: mdl-15617030

ABSTRACT

The purpose of this study was to investigate the oxidative status in experimental hypothyroidism and the antioxidant effect of taurine supplementation. Forty male Sprague Dawley rats were randomly divided into four groups (group 1, control; group 2, control + taurine; group 3, propylthiouracil (PTU); group 4, PTU + taurine). Hypothyroidism was induced by giving 0.05% PTU in drinking water for 8 weeks. Taurine was supplemented in drinking water at a concentration of 1% for 5 weeks. Plasma (p < 0.05), red blood cell (p < 0.01), liver (p < 0.001) and kidney tissue (p > 0.05) malondialdehyde levels were increased in the PTU group compared with those of the control rats and were decreased in the PTU + taurine group compared with the PTU alone group. No significant changes were observed in glutathione levels of kidney and liver in the PTU group, but taurine supplementation significantly increased the glutathione levels of these tissues. Paraoxonase and arylesterase activities were decreased in the PTU group while taurine supplementation caused no significant changes in paraoxonase and arylesterase activities. These findings suggest that taurine supplementation may play a protective role against the increased oxidative stress resulting from hypothyroidism.


Subject(s)
Hypothyroidism/physiopathology , Oxidative Stress/drug effects , Taurine/pharmacology , Animals , Antioxidants/pharmacology , Aryldialkylphosphatase/metabolism , Carboxylic Ester Hydrolases/metabolism , Disease Models, Animal , Glutathione/metabolism , Hypothyroidism/chemically induced , Kidney/metabolism , Liver/metabolism , Male , Malondialdehyde/blood , Propylthiouracil , Rats , Rats, Sprague-Dawley
11.
Cell Biochem Funct ; 23(1): 1-8, 2005.
Article in English | MEDLINE | ID: mdl-15386442

ABSTRACT

Thyroid hormones are associated with the oxidative and antioxidative status of the organism. Since data on the oxidative status of hypothyroidism are limited and controversial, we investigated the oxidant and antioxidant status and serum paraoxonase/arylesterase activities in propylthiouracil-induced hypothyroidism and examined the effect of vitamin E supplementation on this experimental model. Forty male Sprague Dawley rats were randomly divided into four groups (group 1, control; group 2, control + vitamin E; group 3, propylthiouracil; group 4, propylthiouracil + vitamin E). Plasma, red blood cell, liver, heart and skeletal muscle malondialdehyde levels were increased in the propylthiouracil-treated group compared with the control rats and were decreased in propylthiouracil + vitamin E group compared with the propylthiouracil-treated group. Vitamin E supplementation also significantly increased liver and kidney reduced glutathione levels in propylthiouracil treated animals. Serum paraoxonase and arylesterase activities were decreased in propylthiouracil treated group and vitamin E supplementation caused significant increase in serum paraoxonase activity compared with the propylthiouracil-treated rats. These findings suggest that hypothyroidism is accompanied with increased oxidative stress and vitamin E supplementation exerts beneficial effects on this situation.


Subject(s)
Aryldialkylphosphatase/metabolism , Dietary Supplements , Hypothyroidism/metabolism , Oxidative Stress/drug effects , Vitamin E/pharmacology , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Antioxidants/pharmacology , Aryldialkylphosphatase/blood , Aryldialkylphosphatase/drug effects , Body Weight , Disease Models, Animal , Hypothyroidism/blood , Hypothyroidism/chemically induced , In Vitro Techniques , Male , Malondialdehyde/metabolism , Oxidative Stress/physiology , Propylthiouracil , Rats , Rats, Sprague-Dawley , Thyroid Hormones/metabolism , Vitamin E/administration & dosage , Vitamin E/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...